We have previously found evidence for linkage as well as allelic and haplotype association between the myelin basic protein (MBP) gene and multiple sclerosis (MS). These findings have, however, not been reproduced in other populations. Here, we have analyzed association between MBP and MS in a new set of 349 Finnish triad families. Families with a parent born in the Southern Ostrobothnian region in western Finland (Bothnia families, n ¼ 98) were analyzed as a separate group since our previous studies included a high proportion of patients and families from this high-incidence region. Other families (n ¼ 251) were collected at five hospitals in southern, eastern, and northern Finland. The MBP short tandem repeat was genotyped, and haplotype patterns were verified by sequencing. In the Bothnia families, the previously detected associations with the 1.27 kb allele and haplotype 1.27-B10 were confirmed (P ¼ 0.01 and 0.02, respectively), whereas in the other families there was not even a trend toward association. These results demonstrate a geographic/genealogical restriction in the association between MS and the MBP short tandem repeat, highlight the importance of genealogical information in genetic studies of complex traits, and may provide an explanation why the association has not been found in many other populations.
Introduction
Multiple sclerosis (MS) is chronic inflammatory disease of the central nervous system and among the commonest causes of neurological disability in young adults. Pathologically, MS is characterized by multiple foci of myelin lesions, which exhibit infiltrates of leukocytes, especially T lymphocytes and microglia/macrophages. These demyelinative lesions impair the function of myelinated axons and lead to a spectrum of neurological symptoms depending on their anatomical location. 1 There is also increasing evidence for neurodegenerative processes in MS. 2 Most patients present with relapsingremitting disease, in which there are phases of relapses and complete or near-complete remissions. However, in time, neurological disability accumulates and the disease often adopts a secondary progressive course. About 20% of patients do not present with a relapse, but exhibit a primarily progressive disease course from the onset.
The etiology of MS is still largely unknown. It is a multifactorial disease with both genetic and environmental contributing factors. It is believed that environmental, presumably infectious, agents may trigger the disease in genetically susceptible individuals. However, no specific environmental agent has so far been unequivocally implicated. 1 The evidence for the role of genetic factors is strong, and is supported at the epidemiological level by twin, half-sibling, and adoption studies. 3, 4 MS is considered a polygenic disease, yet no specific susceptibility gene has so far been unequivocally identified.
As in many complex disorders, the molecular genetics of MS is featured by several nonreplicated findings. The association with HLA-DR15,DQ6 haplotype is the most convincing and universal finding thus far. 5 Whole genome linkage screens indicate that there is no single major gene but multiple loci with relatively weak effects. A few chromosomal regions, besides HLA, have been supported by two or more genome-wide or more targeted studies, [6] [7] [8] [9] [10] [11] [12] [13] but the chromosomal regions harboring the putative susceptibility genes are still relatively wide. In addition, candidate gene association studies have suggested some potential predisposing loci, but these have not been uniformly confirmed. Myelin basic protein (MBP), a potential autoimmune target 14 in MS and a key player in myelin maintenance and repair, 15 is one of the candidate loci that has generated conflicting results. Association with a tetranucleotide repeat polymorphism just upstream of the MBP promoter was originally reported in a case-control data set from Canada using Southern hybridization technique. 16 Subsequently, using a more accurate PCR/PAGE genotyping system of the same marker, we provided evidence for linkage and association between MS and MBP in Finnish multiplex families and in a Finnish case-control data set. 17 However, these findings have not been confirmed in other populations. [18] [19] [20] [21] [22] [23] [24] [25] [26] We have subsequently replicated the association with alleles of 1.27 kb range in a family data set, and found evidence for haplotype association. 27 Two other associations have been reported, in Danish and Italian data sets, but these studies were based on a different biallelic polymorphic system of the tetranucleotide repeat, and the associated allele was not the same in the two studies. 28, 29 Since MBP is one of the controversial issues in MS genetics, we have here analyzed a collection of 349 MS families, which were not included in our previous studies, in order to confirm and possibly extend our previous findings. We demonstrate the importance of genealogy in the association between MS and MBP since linkage disequilibrium between the MBP short tandem repeat (STR) and the putative susceptibility gene is found only in a geographically restricted sample of families collected from the Southern Ostrobothnian region in Finland. This region is characterized by a stable population and very high incidence of MS. In families from this region we confirmed our previous allelic and haplotypic associations, while the results with families from other regions of Finland did not provide any evidence for an association.
Results
Organization and haplotype diversity of the MBP STR The MBP STR is located approximately 1 kb upstream of the MBP exon 1 and is composed of several blocks of perfect TGGA repeats, interrupted by imperfect repeats. 30 The 5 0 side of the STR contains two highly polymorphic TGGA repeat loci designated B and C that together form locus A (Figure 1) . We sequenced the whole STR from eight and the STR-A,B,C system from 77 chromosomes of the MS families. Sequence analysis of the whole STR revealed that the length polymorphism was mostly concentrated at repeat blocks with more than three perfect repeats. There were six such repeat blocks, of which five were polymorphic among the sequenced chromosomes. Additionally, a 70 bp biallelic insertiondeletion polymorphism was found on the 3 0 side of the STR as previously described.
28 Figure 1 illustrates the distribution of length polymorphism within the STR. Additionally, two previously reported 29 nucleotide substitutions were found as well. The reported nucleotide substitution 31 between STR-B and -C was not detected in any of the 77 chromosomes that were sequenced for the STR-A,B,C system.
The highly polymorphic STR-A,B,C system has been used for genotyping in most previous studies. We used a nondenaturing PAGE system with a higher resolution than previously and found that STR-A exhibited several interalleles that did not follow the expected 4 bp periodicity. Sequence analysis of 77 chromosomes demonstrated that the interalleles (designated with *) resulted from alternate combinations of repeats at STR-B and -C. For example, the interallele A16* (209 bp) was composed of seven repeats at B locus and nine repeats at C locus (B7-C9) and it migrated faster than the equal-sized A16 allele (209 bp) with the B9-C7 combination (Table 1) . These migration alterations are most likely caused by DNA secondary structures in the nondenaturing PAGE. The haplotype combinations of the STR-A,B,C system, based on our sequencing data, are summarized 
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Haplotype diversity of the STR was analyzed in 349 Finnish MS families and 67 French CEPH families. Haplotypes with a frequency of 40.01 in one or both of the family data sets were included in this analysis. There were 18 such haplotypes. These haplotypes could be grouped into six putative haplotype lineages under the assumption of the step-wise mutation model. 32 All haplotypes within these lineages could have evolved through gain or loss of 1-2 repeats at one site, either STR-B, -C, or other repeat blocks within the STR (Figure 2) .
The biallelic insertion/deletion (ins/del) polymorphism was analyzed in the Finnish MS families. The del allele was in complete linkage disequilibrium with the haplotype lineage-1, while the ins allele was always found in lineages 2-6 (data not shown).
Allelic and haplotype associations of the MBP STR with MS We have previously reported an association between MS and alleles at the 1.27 kb range (STR-long) in a casecontrol data set and confirmed it in an independent family data set. 17, 27 To confirm and possibly extend our previous findings, the association of STR-long and the STR-A,B,C system with MS was tested in 349 triad families that were not included in our previous studies. In the total set of families, the association of the STR-long 1.27 kb allele with MS did not reach statistical significance (w 2 ¼ 2.38, 1 df, two-sided test P ¼ 0.12, one-sided test P ¼ 0.06). Our previous data sets included a high proportion of patients from the Southern Ostrobothnia with exceptionally high incidence and prevalence of MS 33, 34 and, hence, we made a separate, geographically defined data set, in which at least one of the patient's parents was born in this region (Bothnia families, Figure  3) . Interestingly, the results of the analysis differed clearly between the 98 Bothnia families and the 251 other families. In the Bothnia families, the previously detected single marker association with the 1.27 kb allele was replicated, while in the other families there was not even a trend toward association with this allele (Table 3 ). In addition, associations with STR-A21* and STR-B10 were found in the Bothnia families (Table 3) , the latter was also associated with MS in our previous case-control data set, although not regarded significant after multiple testing (allele B133 in ref. 27 ). In two-marker haplotype analysis of the Bothnia families, associations were found with 1.27-B10 and 1.27-A21* (Table 3) , which are components of the previously reported MS-associated haplotype 1.27-B133-C94. 27 A single novel positive association was found (haplotype B12-C9) in addition to a few negative associations (Table 3) ; the corrected Pvalues were, however, nonsignificant.
Analysis of three-marker haplotypes resulted in very low numbers of observations per haplotype and loss of power (data not shown). Hence, we focused here on single locus and two-marker haplotype analyses.
Haplotype associations in an extended set of Bothnia families
The above association analysis provides evidence for an association between MS and the haplotype lineage-4 (see Figure 2 ), the components of which are the alleles 1.27 kb, B10 and C11 (A21*). There was also a weak signal for an association with lineage-6 (marked by the B12-C9 haplotype, Figure 2 ), but the corrected P-value was not significant. In order to increase the statistical power, we added to the analysis 28 available Bothnia families that had been included in our previous studies. 17, 27 In the extended set of 126 Bothnia families, the significance of the 1.27-B10 association substantially increased (from P ¼ 0.02 to 0.0003, Table 4 ). Only a modest increase in significance was found for the putative B12-C9 association (from P ¼ 0.04 to 0.02, P c24 ¼ ns, Table 4 ), which remained clearly nonsignificant after Bonferroni correction.
Interaction of the 1.27-B10 haplotype with HLA-DR2 was tested in the extended set of Bothnia families. The association with the 1.27-B10 haplotype was found both in the families with DR2-positive (P ¼ 0.01, 77 families) and DR2-negative patients (P ¼ 0.006, 46 families), suggesting that there would be no interaction with DR2. B7  B121  C7  C78  A17  A211  B8  B125  C8  C82  A18, A18*  A215  B9  B129  C9  C86  A19, A19*  A219  B10  B133  C10  C90  A20, A20*  A223  B11  B137  C11  C94  A21, A21*  A227  B12  B141  C12  C98  A22, A22*  A231  B13  B145  A23 A235
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Discussion
We have confirmed our previous finding of an association between MS and MBP in a new set of MS families. Haplotype patterns at the STR-A,B,C system were verified by sequencing, which provided a higher precision for haplotyping than previously. Interestingly, the observed association with the 1.27 kb allele and 1.27-B10 haplotype appeared to be highly dependent on genealogy. The association was only seen in the MS families from the Southern Ostrobothnian region of Finland (the Bothnia families). These families represent the third independent data set showing association with the 1.27 kb allele and the second independent data set showing association with the 1.27-B10 haplotype lineage (the previously associated haplotype of this lineage was termed 1.27-B133-C94 in ref. 27) . A putative second predisposing haplotype lineage (B12-C9) was also identified but this association did not survive the Bonferroni correction.
The geographical/genealogical restriction may provide an explanation why the association between MBP and MS has not been replicated in other populations. Four linkage studies in MS families from UK, US, and Italy, [18] [19] [20] [21] and seven association studies [19] [20] [21] [22] [23] [24] [25] [26] in data sets from Belgium, Northern Ireland, England, Sweden, Italy, and USA have been published utilizing the STR marker, all of which failed to provide any evidence for a role of MBP in MS susceptibility. A different intragenic dinucleotide marker (with two common alleles) was used in a recent French study, but no evidence for association was found. 35 In addition to our studies from Finland, an association has been found in a Canadian data set, in which the longest allelic forms of the whole STR were Figure 3 Location of the study centers. The subregion surrounding Seinäjoki represents the Southern Ostrobothnian area that was used to define the Bothnia families. This region was defined so that it included the high-prevalence communities of the health-care district of Seinäjoki as well as the Finnish-speaking communities of the health-care district of Vaasa. 34, 37, 38 The population size of this region was 287 757 at 31 December, 2001 (5.4% of the total population of Finland.) associated with MS. 16 In Italian and Danish data sets a weak association has been reported using the ins/del polymorphism, but the associated allele differred in these two studies. 31, 32 Given these inconsistencies, it was important to seek additional evidence in a new set of Finnish MS families.
We have been fortunate to include a relatively high proportion of Southern Ostrobothnian MS families in our data sets. In our first case-control and in the subsequent family-based association studies 30 and 26% of the patients were from Southern Ostrobothnian region, respectively. 17, 27 The remaining patients were collected from one hospital district (Helsinki) but the birth places of the patient's parents were not systematically recorded at that time. In the present study, the total data set included 26% of patients who had a parent born in Southern Ostrobothnia, while the majority of the other families originated from various locations of Finland, Positive association, Bonferroni-corrected P c24 =ns.
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MBP linkage disequilibrium and multiple sclerosis H Pihlaja et al collected from five different centers from southern, eastern and northern Finland. Hence, the other families in the present data set are probably more heterogeneous in terms of genealogy as compared to our previous data sets. Our present results emphasize the importance of genealogical information in genetic studies of complex traits, and gathering of this information should apparently be a routine procedure in such studies. With this information, it should be possible to form more homogeneous data sets with obvious benefits in linkage disequilibrium detection. 36 Does the observed geographic restriction in the association reflect etiological difference according to geography/genealogy, or difference in the extent of linkage disequilibrium between the marker and the putative susceptibility gene? Pertinent issues to be considered are: (i) the clinical picture of MS in Southern Ostrobothnia vs other regions, (ii) the nature of the marker, and (iii) linkage disequilibrium in subisolates.
First, in epidemiological surveys since 1960s, the Southern Ostrobothnia, especially its Finnish-speaking part, has stood out as a region with significantly higher incidence and prevalence of MS compared to other parts of Finland. 33, 34, 37 The incidence of 11.6/10 5 for definite MS is among the highest ever reported. 33 Moreover, remarkable familial clustering of MS has been reported in this region. 38, 39 We have recently found subtle differences in the clinical and demographic profile of MS in the Southern Ostrobothnian region, especially in the health-care district of Seinäjoki, as compared to other parts of Finland. Differences have been observed at the level of sex ratio, disease course, and presenting symptoms. A lower female-to-male ratio (1.6 vs 2.4) was found in the recent incidence study 33 in Seinäjoki as compared to Uusimaa, a region in the southern Finland, where Helsinki, the capital city, is located. Moreover, primarily progressive MS was more common in Seinäjoki (30% of patients) as compared to Uusimaa (20% of patients), and motor symptoms were more common and sensory symptoms less common in Seinäjoki than in Uusimaa. 40 However, all the above differences are well within the range of variation that can be found when cohorts from different populations are compared. In the recent incidence study, intrathecal IgG synthesis, a marker of ongoing neuroinflammation, was observed in 92% of patients in Seinäjoki (96% were tested), indicating that diagnostic misclassification (eg spastic paraparesis) should not be common among these patients. 40 In most cohorts, 90-95% of MS patients exhibit intrathecal IgG synthesis. 1 In the present study, 59% of the patients in the Bothnia families were HLA-DR2 positive, which matches well with previous studies from Finland. 41, 42 Taken together, subtle differences in the clinical and demographic profile have been found in the Southern Ostrobothnian patients, but these do not allow us to delineate any distinct subtype of MS characteristic to this region.
Second, the STR marker belongs to the group of highly polymorphic microsatellites, which tend to mutate, predominantly via step-wise mutations. 32 The data on the haplotype lineages in the Finnish MS families and in the CEPH families fit well with the step-wise mutation model. A mutation frequency of 1.5% was recently reported for this marker in the Danish population. 43 In our data sets, however, the de novo mutation frequency appears to be much lower, approximately 0.2% (unpublished), which is close to that reported for various other highly polymorphic tetranucleotide markers. 32 Nevertheless, due to marker mutations linkage disequilibrium between the microsatellite and the predisposing gene may decay relatively rapidly in successive generations.
Third, it has been shown that the extent of linkage disequilibrium between adjacent markers tends to be greater in certain subpopulations as compared to the general population level. 36, 44, 45 For instance, regional subpopulations, such as Saami in the northern Finland and Sweden, exhibit a much higher degree of linkage disequilibrium than the general population of Finland or Sweden. 45 Southern Ostrobothnia is a rural area that can be considered a subisolate in Finland, although not to the extent of Saami. The present population of Southern Ostrobothnia is believed to descent from migrants that populated this area between the 13th and 15th century. 46 These immigrants came from Sweden (inhabitating the coast) and from two distinct locations of the neighboring southern area (Satakunta and Pirkanmaa). 46 The coast became mostly Swedish-speaking while the language of the inland was Finnish. After the 15th century, immigration is believed to have gradually ceased. Since then, the population grew from multiple foci of small founder communities, which gradually inhabitated larger areas. 46 In the 19th century, there was a phase of rapid population growth, which resulted in a wave of emigration to Sweden, to northern states of USA and to Canada from 1850s to 1920s. For the past 100 years, there has been very little population growth in the Southern Ostrobothnia. Since immigration has been at a very low level for centuries, it is likely that a relatively large portion of the present population descent from the founders. Moreover, population bottlenecks caused by plague (14th century) and famines (17th and 19th century) have shaped this isolated founder 
MBP linkage disequilibrium and multiple sclerosis H Pihlaja et al population. 36, 46 It is of note that more than half of the approximately 450 000 Finnish emigrants to North America during 1850-1920 were from Southern Ostrobothnia or the coastal area just north of it (collectively called the Ostrobothnia). In the light of this, it is not surprising that in the early 20th century epidemiological surveys of MS in the USA (by Charles Davenport), the Finns were the immigrant population with the highest prevalence of MS, when the country of origin was considered. 47 The findings on the second putative predisposing haplotype (B12-C9), although not statistically significant, are worthy of a comment. This is the same haplotype that was sequenced by Boylan et al. 30 representing 'the longest allelic form of this region seen in Southern transfer analysis'. This was also the allelic form that associated with MS in the Canadian case-control data set. 16 It is an interesting coincidence that the second putative predisposing haplotype corresponds to the one that was originally associated with MS.
Our previous and present results on MBP association with MS heavily relied on the Bothnia families. Whether this geographic restriction reflects differences in etiology or in linkage disequilibrium detection remains to be seen. However, taken together what was discussed above, we prefer the interpretation that the main factor would be linkage disequilibrium detection and we anticipate that the MBP-linked locus might not be a subpopulationspecific ''domestic gene'', 4 but would play a role in other populations as well. Further work will be directed to unravel single nucleotide polymorphism-based association with MBP, which may lead to the discovery of more stable markers for more reliable testing in different populations. This should also facilitate fine mapping and eventual identification of the putative etiological variant(s).
Subjects and methods
Patients and families MBP genotyping was performed in 349 triad families of which DNA was available at the end of year 2000. The families were collected from six centers in Finland. The centers were the University Central Hospitals of Helsinki (n ¼ 44 families), Turku (n ¼ 117), Tampere (n ¼ 13), Kuopio (n ¼ 62), Oulu (n ¼ 13), and the Central Hospital of Seinäjoki (n ¼ 100). These patients or families were not included in our previous case-control or family-based association studies. 17, 27 Table 5 illustrates the demographic features of the families, which we divided into two groups based on the parents' birthplace. The birthplaces of the patients' parents were inquired by a questionnaire from both the patients and their parents (if alive). The Southern Ostrobothnian families were analyzed as a group of its own (Bothnia families, at least one parent born there, Figure 3 ).
All patients had clinically definite or laboratorysupported definite MS according to the Poser criteria. No selection was made as to the disease course, hence there were patients with relapsing-remitting, primarily progressive and secondary progressive course. 
Genotyping
Peripheral blood leukocytes were used for DNA extraction. All markers were PCR-amplified from genomic DNA using the protocols previously described. 17, 27 We used 50-cm-long nondenaturing PAGE to separate the MBP STR alleles. For the long alleles, we used 5% acrylamid/bisacrylamid (29 : 1), 5% glycerol, 0.6 Â TBE. The gel was run at 1550 V for 2 h and at 1500 V for 3 h 15 min, at +41C. For the STR-A,B,C system we used 8% acrylamid/bisacrylamid, 1 Â TBE. The gel was run for 16 h using 500 V, at room temperature. The ins/del polymorphism was genotyped as described. 28 HLA-DR2 typing was based on allele-specific PCR or hybridization with sequence-specific oligonucleotide probes using the previously described protocols. 41, 48 Sequencing Eight alleles were sequenced for the whole length of the STR and 77 additional alleles were sequenced for the STR-A. The whole STR sequencing was accomplished via cloning of the PCR-amplified STR-long and its shorter fragments generated with alternate combinations of the previously published primers 17, 27, 28 and by digestion of the STR-long into two fragments with SphI. The sequence was verified from several clones of two independent PCR/ligation reactions of the same sample. s PE Applied Biosystems) from 20 subjects that were homozygous for STR-A and STR-B, and 10 subjects that were homozygous for STR B. In addition, 17 distinct STR-A alleles obtained from heterozygous individuals were sequenced after separation and purification from PAGE.
Statistical analysis
The association of MBP markers with MS was analyzed by transmission disequilibrium test (TDT). For this purpose we used the Transmit 2.5.2 software, which is able to deal with multilocus haplotypes, when some of the parental genotype information is missing. 49 P-values were not corrected, when previously reported associations, such as the 1.27 kb allele and the 1.27-B10 haplotype lineage were considered. Two-sided P-values were used, unless otherwise stated. Bonferroni correction was used for novel associations. Because of linkage disequilibrium between alleles of different markers and common lineages of certain distinct haplotypes, it is not obvious how the correction factor should be defined. We have applied a reasonably conservative correction factor of 24, which was based on the eight tested STR-long-STR-A haplotypes in Table 3 (the marker combination with the largest number of tests) plus the dichotomies of the families with respect to the patients' parents' birthplace and patients' HLA-DR2 carrier status.
